Cleveland Cord Blood Center and Deverra Therapeutics Announce AgreementManufacturing Service Agreement • April 5th, 2022
Contract Type FiledApril 5th, 2022Since 2018, CCTI and Deverra have successfully collaborated on supply programs utilizing frozen cord blood products. To support Deverra’s next mid-stage clinical development programs, Deverra Therapeutics has selected CCTI for the manufacturing of the required clinical grade materials.